Medifast Announces Second Quarter 2025 Financial Results
MEDBALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2025. Second Quarter 2025 Revenue: $105.6 million, with revenue per active earning coach of $4,630 Active Coaches: Independent active earning OPTAVIA coaches of 22,800 Net Income: $2.5 million or $0.22 per diluted share, which includes a gain on investment in LifeMD (Nasdaq: LFMD) c
Is Medifast Gaining or Losing Market Support?
MEDMedifast Q2 expected to be more than $(0.55) vs $(0.08) Est; Sees Q2 Sales $85.000M-$105.000M vs $111.20M Est
MEDMedifast Q1 EPS $(0.07) Beats $(0.27) Estimate, Sales $115.73M Beat $110.10M Estimate
MEDUncovering Potential: Medifast's Earnings Preview
MEDHow Is The Market Feeling About Medifast?
MEDDA Davidson Maintains Neutral on Medifast, Lowers Price Target to $16.5
MEDMedifast Q1 expected to be $0 to $(0.50) vs $(0.19) Est; Sees Q1 Sales $100.000M-$120.000M vs $130.75M Est
MEDMedifast Q4 Adj $0.10 Beats $(0.16) Estimate, Sales $119.00M Beat $114.25M Estimate
MEDDA Davidson Upgrades Medifast to Neutral, Raises Price Target to $17
MEDMedifast Sees Q4 GAAP EPS $0.10-0.65 vs $(0.18) Est; Sees Sales $100.000M-120.000M vs $129.95M Est
MEDMedifast Q3 2024 Adj. EPS $0.35 Beats $(0.28) Estimate, Sales $140.163M Beat $134.150M Estimate
MEDMedifast: Dividend Insights
MEDFriday marks the last chance for investors to receive the next dividend payout from Medifast (NYSE:MED).
Recap: Medifast Q1 Earnings
MEDMedifast (NYSE:MED) reported its Q1 earnings results on Monday, May 2, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Medifast beat estimated earnings by 0.56%, reporting an EPS of $3.59 versus an estimate of $3.57.
UPDATE: Medifast Raises FY22 Guidance: Sales From $1.72B-$1.79B To $1.78B-$1.84B vs $1.77B Estimate, EPS From $14.50-$16 To $14.60-$16.05 vs $15.62 Est.
MEDMedifast Q1 EPS $3.59 Beats $3.57 Estimate, Sales $417.60M Beat $403.25M Estimate; Raises Guidance
MEDEarnings Outlook For Medifast
MEDMedifast (NYSE:MED) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement.
Analysts estimate that Medifast will report an earnings per share (EPS) of $3.56.
